General News

RMS announces hiring of Eric Bauer as Chief Operating Officer

CHESTER, NY / January 20, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS” or the “Company”) announced today that Mr. Eric Bauer has joined the executive team as Chief Operating Officer, effective January 17, 2017.  Mr. Bauer brings to RMS over 25 years of experience driving operational excellence in growing … Continued

RMS Medical Products Posts Third Quarter 2017 Results

The Company announced that its net revenues for the third quarter ended November 30 of fiscal 2017 were $3,193,113 compared with $3,144,954 for the third quarter of fiscal 2016. Net loss for the quarter was $104,275 compared with net income of $167,552 for the same period last year. For the nine months ended November 30, … Continued

RMS Announces New Board Member

Effective May 13, 2016, Joseph Manko, Jr. was appointed as an additional member of the Board of Directors of Repro Med Systems, Inc. Mr. Manko is the Senior Principal in Horton Capital Management LLC, the investment manager for the Horton Capital Partners Fund, LP (“Horton Fund”). The Horton Fund is a significant shareholder in the … Continued

RMS Appoints New President

On April 26, 2016, the Board of Directors of Repro Med Systems, Inc. (the “Company”) appointed Mr. Cyril Narishkin as President of the Company to replace Mr. Andrew Sealfon. Mr. Sealfon remains as the Company’s Chief Executive Officer and head of research and development.

Investor Updates

RMS Appoints New COO

On January 17, 2017, Repro Med Systems, Inc. dba RMS Medical Products (“RMS”) hired Mr. Eric Bauer as its Chief Operating Officer, effective immediately.

RMS Medical Products Posts Third Quarter 2017 Results

The Company announced that its net revenues for the third quarter ended November 30 of fiscal 2017 were $3,193,113 compared with $3,144,954 for the third quarter of fiscal 2016. Net loss for the quarter was $104,275 compared with net income of $167,552 for the same period last year. For the nine months ended November 30, … Continued

Prelim Proxy

All shareholders are invited to attend the Annual Meeting. Only those stockholders of record at the close of business on July 18, 2016 are entitled to notice of and to vote at the Annual Meeting and any postponements or adjournments thereof. A complete list of shareholders entitled to vote at the Annual Meeting will be … Continued